Inhibitory CARs fail to protect from immediate T cell cytotoxicity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibitory CARs fail to protect from immediate T cell cytotoxicity

Published:2024-04 Issue:4 Volume:32 Page:982-999
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Funk Maximilian A.^ORCID,Heller Gerwin^ORCID,Waidhofer-Söllner Petra,Leitner Judith^ORCID,Steinberger Peter^ORCID

Funder

FWF

City of Vienna

Publisher

Elsevier BV

Reference86 articles.

1. Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours;Flugel;Nat. Rev. Clin. Oncol.,2023

2. Recent advances and discoveries in the mechanisms and functions of CAR T cells;Larson;Nat. Rev. Cancer,2021

3. Hypogammaglobulinemia After Chimeric Antigen Receptor (CAR) T-Cell Therapy: Characteristics, Management, and Future Directions;Wat;J. Allergy Clin. Immunol. Pract.,2022

4. Treatment of metastatic renal cell carcinoma (mRCC) with CAIX CAR-engineered T-cells - A completed study overview;Lamers;Biochem. Soc. Trans.,2016

5. The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T cells is limited by poor persistence and transient pre-conditioning-dependent respiratory toxicity;Thistlethwaite;Cancer Immunol. Immunother.,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. T cell-redirecting therapies in hematological malignancies: Current developments and novel strategies for improved targeting;Molecular Therapy;2024-09

2. Synthetic Gene Circuits as a Promising Approach in Cancer Immunotherapy;Advances in Medical Diagnosis, Treatment, and Care;2024-08-28

3. BTLA and PD-1 signals attenuate TCR-mediated transcriptomic changes;iScience;2024-07

4. The BTLA–HVEM axis restricts CAR T cell efficacy in cancer;Nature Immunology;2024-06

5. Experience of Youths and Older People With Virtual Reality Games for Cognitive Assessment: Inductive Thematic Analysis and Insights for Key Stakeholders (Preprint);2024-04-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3